Skip to content
healthcare.dev

Cisatracurium Besylate

NDC 55150-284, Cisatracurium Besylate, injection, from Eugia US LLC.

Product NDC
55150-284
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209665
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE10 mg/5mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
55150-284-105515002841010 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1 VIAL, SINGLE-DOSE (55150-284-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2cb05c7e-6228-4e2d-a270-7659e3db3fa7

Use it

Look up 55150-284 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-284 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.